Skip to main content

Gryska David W

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gryska David W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

DFTX Definium Therapeutics, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 5, 2024 (view filing)Dec 5Same dayGryska David WDirectorPPurchase+2.50K$7.17+$17.9K+14.4%19.9K after
Aug 26, 2024 (view filing)Aug 233 daysGryska David WDirectorPPurchase+3.50K$5.98+$20.9K+25.3%17.4K after

SGEN Seagen Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 15, 2022 (view filing)Nov 114 daysGryska David WDirectorSSale−7.50K$129.10−$968.3K−15.7%40.3K after
Apr 21, 2022 (view filing)Apr 192 daysGryska David WDirectorSSale−4.00K$143.95−$575.8K−8.0%46.3K after3 lots
Feb 9, 2022 (view filing)Feb 72 daysGryska David WDirectorSSale−4.50K$138.76−$624.4K−8.9%46.3K after3 lots
Feb 1, 2022 (view filing)Jan 284 daysGryska David WDirectorSSale−4.50K$122.56−$551.5K−8.9%46.3K after4 lots
Jan 19, 2022 (view filing)Jan 145 daysGryska David WDirectorSSale−4.50K$135.24−$608.6K−8.9%46.3K after